1Sacks FM.The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.AM J cardiol, 2002,90:139-143.
2Navab M, Van Lenten BJ, Reddy ST, et al. High-density lipoprotein and the dynamics of atherosclerotic lesions. Circulation,2001,104:2386-2387.
3Rong JX, Li J, Reis ED, et al.Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions bydecreasing macrophage and increasing smooth muscle cell content. Ciculation,2001,104:2447-2452.
同被引文献14
1Toth PP, Davidson MH. Therapeutic interventions targeted at the augmentation of reverse cholesterol transport [J]. Curr Opin Cardiol,2004,19(4):374-379.
2Shaul PW, Miaeo C. HDL action on the vascular wall:is the answer NO[J]? J Clin Invest,2004,113(4) :509-513.
3Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis:the role of oxidized phospholipids and HDL[J]. J Lipid Res,2004,45(6) :993-1007.
4Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes : a randomized controlled trial [J]. JAMA ,2003,290( 17 ) :2292-2300.
5Clark RW, Sutfin TA, Ruggeri RB, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein : an initial multidose study of torcetrapib [J]. Arterioscler Thromb Vasc Biol,2004,24(3):490-497.
6Brousseau ME, Schaefer EJ, Wolfe ML, et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol[J]. N Engl J Med, 2004, 350( 15 ) : 1505-1515.
7Davidson MH, Maki K, Umporowicz D, et al. The safety and immunogenicity of a CETP vaccine in healthy adults[ J]. Atherosclerosis,2003,169( 1 ) :113-120.
8Chetiveaux M, Ouguerram K, Zair Y, et al. New model for kinetic studies of HDL metabolism in humans[J]. Eur J Clin Invest, 2004,34(4) :262-267.
9Natarajan P, Forte TM, Chu B, et al. Identification of an apoli-poproteinA-I structural element that mediates cellular cholesterol efflux and stabilizes ABCA1 [J]. J Biol Chem, 2004,279 ( 23 ) :24044-24052.
10Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J]. Circulation,2003,108 ( 22 ) :2751-2756.
